Press release - 25/01/2010 Amedrix GmbH - New investment paves the way for own production operations The High-Tech Gründerfonds (HTGF) and Life Science Fonds Esslingen are jointly investing a total of 700,000 EUR in Amedrix GmbH, which was founded in January 2009. The Esslingen-based company develops innovative, acellular medical products based on animal collagen for wound regeneration and the reconstruction of degenerated soft tissue, for example. The new investment means that necessary steps can be taken to gain approval for first medical…https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-new-investment-paves-the-way-for-own-production-operations
Press release - 14/01/2010 Deep brain stimulation successful for treatment of severely depressive patient A team of neurosurgeons at Heidelberg University Hospital and psychiatrists at the Central Institute of Mental Health, Mannheim have for the first time successfully treated a patient suffering from severe depression by stimulating the habenula, a tiny nerve structure in the brain. The 64-year-old woman, who had suffered from depression since age 18, could not be helped by medication or electroconvulsive therapy. Since the procedure, she is for…https://www.gesundheitsindustrie-bw.de/en/article/press-release/deep-brain-stimulation-successful-for-treatment-of-severely-depressive-patient
Press release - 24/09/2009 Call for innovative technologies that address global health concerns The World Health Organization is seeking innovative technologies, in particular medical devices that offer solutions to global health concerns in low- and middle-income countries. The deadline for submission of proposals is January the 31st 2010.https://www.gesundheitsindustrie-bw.de/en/article/press-release/call-for-innovative-technologies-that-address-global-health-concerns
Press release - 24/09/2009 Researchers successfully colonize a textile implant with human stem cells Researchers at the Hohenstein Institute in Stuttgart, Germany developed a method to embed multipotent mesenchymal stem cells onto the surface fibers of common surgical fabric implants. Using such a product it may be possible to directly motivate the regrowth of critical tissue, such as myocardium after a heart attack. https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-successfully-colonize-a-textile-implant-with-human-stem-cells
Press release - 18/09/2009 BioRegio STERN initiates cooperation with French medtech network The STERN BioRegion and Ple Technologique de Haute-Champagne are looking to promote cooperation between French and German companies and research institutes in the medtech and associated sectors. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bioregio-stern-initiates-cooperation-with-french-medtech-network
Press release - 15/09/2009 Nose drops rather than transplantation – an alternative and complementary method to animal testing On 14th September 2009 the physician Dr. Lusine Danielyan from Tübingen was awarded the Förderpreis Ersatz- und Ergänzungsmethoden zum Tierversuch des Landes Baden-Württemberg Prize for alternative and complementary methods to animal testing in Stuttgart. The young scientist who works in the Department of Clinical Pharmacology at the Institute of Experimental and Clinical Pharmacology and Toxicology at the University Hospital of Tübingen has…https://www.gesundheitsindustrie-bw.de/en/article/press-release/nose-drops-rather-than-transplantation-an-alternative-and-complementary-method-to-animal-testing
Press release - 08/09/2009 Angiogenesis as a key for tissue engineering The German Research Foundation is to fund a research priority of the Department of Plastic Surgery at the Freiburg University Medical Centre. Researchers around the world working in the area of regenerative medicine are all equally hopeful of generating tissue replacements using modern tissue engineering. The development of tissue cells on carrier materials seems quite promising. However, tissue-engineered implants are often rejected by patients…https://www.gesundheitsindustrie-bw.de/en/article/press-release/angiogenesis-as-a-key-for-tissue-engineering
Press release - 10/08/2009 Identification of an important mechanism for the production of stem cells Dr. Jochen Utikal, a dermatologist at Mannheim University Hospital, has made decisive progress in the use of cell replacement therapies for the treatment of degenerative diseases. Dr. Utikal succeeded in deciphering a mechanism that enables the successful creation of induced pluripotent stem cells (iPS). Utikal is a chief physician in the Department of Dermatology, Venerology and Allergology (Mannheim Dermatology Excellence Centre) at Heidelberg…https://www.gesundheitsindustrie-bw.de/en/article/press-release/identification-of-an-important-mechanism-for-the-production-of-stem-cells
Press release - 28/07/2009 New trachea made from human tissue A team of doctors from the Schillerhöhe Hospital, which is part of the Robert Bosch Hospital in Stuttgart, in cooperation with researchers from the Fraunhofer Institute of Interfacial Engineering and Biotechnology IGB in Stuttgart, has developed a method that enables artificially produced autologous tissue to be implanted into patients with severe tracheal injuries. The method involves the cultivation of extensive parts of the human trachea and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-trachea-made-from-human-tissue
Article - 12/05/2009 Islet cell transplantation gives new hope to diabetics Establishing a medical therapy requires a great deal of patience. An interdisciplinary group of researchers at the University Hospital Tübingen knows this from experience. It took more than three years before researchers succeeded in transplanting insulin-producing cells. However, the huge effort has paid off two-fold: the diabetes sufferer feels well after the intervention and secondly, Tübingen became the first German centre to receive the…https://www.gesundheitsindustrie-bw.de/en/article/news/islet-cell-transplantation-gives-new-hope-to-diabetics
Article - 20/04/2009 Anita Ignatius makes biomaterials smart Anita Ignatius is not interested in knowledge just for the sake of knowledge. “I have always been interested in the practical application of knowledge,” said the 45-year-old veterinarian. Highly theoretical courses she had to attend during her studies put an end to her dreams of opening her own practice after university. But this experience also had its advantages, because it helped her realise what she really wanted – namely doing research of…https://www.gesundheitsindustrie-bw.de/en/article/news/anita-ignatius-makes-biomaterials-smart
Press release - 20/04/2009 Help for coronary vessel constrictions – Tübingen cardiologists have developed an alternative to drug eluting stents Prof. Christian Herdeg at the University Hospital of Tübingen has developed an alternative approach for intracoronary pharmacotherapy for the treatment of patients with constricted coronary vessels. Localised drug delivery using special catheters is far superior to the use of uncoated stents and is also a way of avoiding the disadvantages of coated i.e. drug eluting stents. On 16th April 2009 the new method was awarded a prize at a meeting of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/help-for-coronary-vessel-constrictions-tuebingen-cardiologists-have-developed-an-alternative-to-drug
Article - 05/04/2009 JOTEC – artificial blood vessel specialist JOTEC GmbH a medical device company based in Hechingen has a broad range of solutions on offer for the therapy of vascular diseases including artificial blood vessels and stentgrafts and is an international leader in this field. The company not only produces traditional vascular grafts from high-quality plastics but also absorbable bioartificial vascular grafts and cell-coated grafts made from biomaterials. Such an approach is currently unique in…https://www.gesundheitsindustrie-bw.de/en/article/news/jotec-artificial-blood-vessel-specialist
Press release - 01/04/2009 Miniature proteins for safe implants Scientists at the Institute for Biological Interfaces IBG at the KIT - Karlsruhe Institute of Technology have succeeded in identifying highly effective protein chains which have the potential of being used as part of an anti-inflammatory protection layer on implants. https://www.gesundheitsindustrie-bw.de/en/article/press-release/miniature-proteins-for-safe-implants
Press release - 08/01/2009 ILM – Bioactive interfaces It is particularly important to consider the biocompatibility of material interfaces. For example, implant materials with a surface composition that favours cell growth have a decisive advantage. However there are other cases where biophobic material characteristics might be more suitable. For example, specifically modifying the surface of surgical metals might prevent pathogens from attaching and could also make the cleaning and deactivation of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-bioactive-interfaces
Article - 26/11/2008 Tetec AG opens new production facility On 20th November 2008 Tetec AG opened a new facility for the production of cartilage transplants. The company market leader and a subsidiary of B. Braun Melsungen AG based in Reutlingen is expanding its production capacities.https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-ag-opens-new-production-facility
Press release - 10/11/2008 Trachea replacement made from pig intestines In principle human tracheas and porcine small intestines do not have much in common. However both have a tube-like structure. This was the basis for Dr. Thorsten Walles extraordinary idea. In collaboration with Professor Dr. Heike Mertsching he is working on the development of methods for turning the intestines into bioartificial trachea substitutes.https://www.gesundheitsindustrie-bw.de/en/article/press-release/trachea-replacement-made-from-pig-intestines
Press release - 01/10/2008 Carsten Mehring - Understanding and using the neuronal code Dr. Carsten Mehring became the head of a junior researcher group at the Institute of Biology at the University of Freiburg just after finishing his PhD. His concept of coupling the brain to computers has been given the GO-Bio Award of the BMBF. At some stage in the future the brain-machine interface developed by Mehring and his team will enable paralysed patients to move body parts by thought power alone. Mehring is highly fascinated by the brain…https://www.gesundheitsindustrie-bw.de/en/article/press-release/carsten-mehring-understanding-and-using-the-neuronal-code
Press release - 30/09/2008 Harald Krug is investigating the use of new materials Prof. Dr. Harald Krug a toxicologist who runs the Materials-Biology Interaction division at Empa - Swiss Federal Laboratories for Materials Testing and Research in St. Gallen Switzerland and his team are investigating the interactions of synthetic materials with biological systems. The team of 25 researchers is focusing in particular on the effect of particles and nanomaterials such as CNT on human and animal cells. The division has been an…https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-krug-is-investigating-the-use-of-new-materials
Article - 15/08/2008 Health research with microsystems The NMI Natural and Medical Sciences Institute in Reutlingen organised its biannual MEA conference from 8 to 11 July 2008. More than 200 developers and microelectrode array users from 18 countries came together in Reutlingen to present their latest developments and results.https://www.gesundheitsindustrie-bw.de/en/article/news/health-research-with-microsystems
Article - 10/08/2008 Technology transfer through dialogue The new iNNOVATION fORUM of the Baden-Württemberg MicroMountains Network offered researchers and the medical device industry an intensive moderated dialogue and the chance to make new contacts and to improve their chances for future innovations.https://www.gesundheitsindustrie-bw.de/en/article/news/technology-transfer-through-dialogue
Article - 09/06/2008 The brain can learn to hear again Cochlear implants can restore hearing to many of those afflicted with deafness. Prof. Robert Illing from the University of Freiburg explores the plastic properties of the nervous system that facilitate the application of these implants.https://www.gesundheitsindustrie-bw.de/en/article/news/the-brain-can-learn-to-hear-again
Article - 07/06/2008 Life-saving surgery for high-risk patients A new surgical repair of the aorta that obviates the necessity to open the thorax and the abdominal cavity is highly suited to high-risk patients that could not previously be operated due to concomitant diseases or previous surgery. https://www.gesundheitsindustrie-bw.de/en/article/news/life-saving-surgery-for-high-risk-patients
Article - 20/05/2008 Hugo Hämmerle: At the crossroads between research and industry The NMI Natural and Medical Sciences Institute in Reutlingen is a role model for how research findings can be turned into financially sustainable products and services. Prof. Hugo Hämmerle has been a key figure in this success story for over 20 years. In February 2008 he took over as Managing Director of the institute. https://www.gesundheitsindustrie-bw.de/en/article/news/hugo-haemmerle-at-the-crossroads-between-research-and-industry
Press release - 13/05/2008 Interfaces between brain and computer The German Federal Ministry of Education and Research BMBF is to finance a new Bernstein Focus on Neurotechnology at the Universities of Freiburg and Tübingen with funds totalling ten million euros. The new initiative is part of the Computational Neuroscience funding programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/interfaces-between-brain-and-computer